Abiomed (ABMD) has announced that the US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to …
Abiomed (ABMD) said that the U.S.
ABIOMED (NASDAQ:ABMD) is a Zacks Rank #1 (Strong Buy), and as such, we know that earnings estimates are moving higher. The company is …
William Blair analyst Ben Andrew maintained an Outperform rating on Abiomed (NASDAQ:ABMD), following the release of the company’s fiscal third-quarter results that topped Street …
In a research report issued today, William Blair analyst Matthew O’Brien maintained an Outperform rating on Abiomed (NASDAQ:ABMD), following the company’s clinical trial results …
